This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange gained a fraction to 805.93 Monday. Joe Boury's halted, four-year-old capital pool shell, Plicit Capital Corp. (PLP), has submitted a filing statement for its qualifying transaction. It is acquiring 3D Signatures Inc., a medical device company in Winnipeg. In connection with the QT, Plicit has rolled back 1 for 2, leaving it with 5.05 million postconsolidated shares issued. To acquire 3D Signatures, the shell will issue 25,323,161 postconsolidated shares to its target's shareholders. Plicit and 3D have received conditional exchange approval for the QT. They expect to close it by Aug. 31.

Currently, Plicit is selling a $5-million private placement of 14,285,715 postconsolidated shares at 35 cents. The resulting issuer will use the proceeds primarily for clinical trials. 3D Signatures is developing a diagnostic and prognostic device that analyzes the shapes of chromosomes, particularly of their tips. According to the company, the appearance of the tips of chromosomes could indicate whether a person has a certain disease. It could also "determine how a disease will progress and if a patient will respond to treatment." 3D Signatures has conducted clinical trials of its device for Alzheimer's disease and 13 types of cancers. Currently, it has a clinical trial in progress for Hodgkin's lymphoma. Within the next 12 months, it expects to begin a study for prostate cancer.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS